Leg­is­la­tors, reg­u­la­tors must act to ad­dress run­away drug prices

Modern Healthcare - - COMMENT -

Thank you for the com­pelling and im­por­tant ar­ti­cle on drug prices and how they are af­fect­ing hos­pi­tals (“Drug price hikes may be hit­ting hos­pi­tals harder than con­sumers,” Mod­ern­Health­care.com, Oct. 11). Hy­per­in­fla­tion tar­get­ing con­sumer drug pric­ing has re­ceived a great deal of me­dia at­ten­tion. The study spon­sored by the Amer­i­can Hos­pi­tal As­so­ci­a­tion and the Fed­er­a­tion of Amer­i­can Hos­pi­tals dis­cussed in the ar­ti­cle brought to light the fact that drug pric­ing is a larger prob­lem for hos­pi­tals and af­fects the hos­pi­tal’s abil­ity to con­trol pa­tient treat­ment costs.

It’s a huge con­cern to all of us work­ing in health­care and the phar­macy sec­tor specif­i­cally as we em­ploy a range of strate­gies to man­age drug pric­ing, both to con­sumers and to hos­pi­tals. It’s just com­mon sense that if drug pric­ing con­tin­ues to out­pace payer re­im­burse­ments, then pa­tients will not get the med­i­ca­tions they need to get bet­ter and man­age their health is­sues. A block­buster drug helps no one if no one can af­ford it. This is a loom­ing cri­sis for health­care in our coun­try, and we join the hos­pi­tal or­ga­ni­za­tions in call­ing for leg­is­la­tors and reg­u­la­tors to act.

Rod Recor Chief strat­egy of­fi­cer Com­pre­hen­sive Phar­macy Ser­vices Mem­phis, Tenn.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.